Genomics and Molecular Services

Our advanced genomics platform combines whole genome sequencing (WGS), genotyping, and variant calling with multiplex digital PCR (dPCR) to deliver comprehensive, high-resolution insights for drug development and precision medicine.

Whole Genome Sequencing (WGS): Unlock complete genomic information to identify novel biomarkers, understand disease mechanisms, and accelerate therapeutic discovery.

Genotyping & Variant Calling: Detect single nucleotide variants (SNVs), insertions, deletions, and structural changes with exceptional accuracy, supporting robust genetic analysis for clinical research.

Multiplex dPCR Approaches: Validate and quantify multiple targets simultaneously with unparalleled sensitivity and reproducibility—ideal for rare mutation detection, copy number variation analysis, and gene expression studies.

By integrating NGS and dPCR technologies, we provide end-to-end solutions that empower biotech and pharmaceutical innovators to make faster, data-driven decisions in early-stage development and translational research.

Precise target quantification, via hLAB’s real-time quantitative PCR (RT-qPCR) for use in either preclinical or clinical samples. For example, this technique can be used to provide critical data on viral load with high accuracy and reliability. Similarly, this technique can be applied to any host or pathogen genomes.